Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Raikhel, Marina
APOLLOE4-LTE, NCT06304883: Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects	Enrolling by invitation	3	285	Europe, Canada, US	Experimental: ALZ-801	Alzheon Inc.	Early Alzheimer's Disease	12/25	01/26
NCT05312567: FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms	Completed	2	105	US	FP-101	Fervent Pharmaceuticals, ICON plc	Vasomotor Symptoms, Menopause	04/23	07/23
NEPTUNE-17, NCT05838755: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain	Active, not recruiting	2	145	Europe, Canada, Japan, US, RoW	GSK3858279, Placebo	GlaxoSmithKline	Pain	10/24	01/25
NCT05138822: Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections	Completed	1	140	US	GSK3882347, Nitrofurantoin, Placebo	GlaxoSmithKline	Uncomplicated Urinary Tract Infections, Urinary Tract Infections	12/24	12/24